Skip to main content
. Author manuscript; available in PMC: 2010 May 12.
Published in final edited form as: Cancer. 2008 Dec 1;113(11):3153–3159. doi: 10.1002/cncr.23918

Appendix 1.

Estimated Radiation Dose to the Salivary Gland From Typical Radiotherapy Fields Used in the Treatment of Hodgkin Lymphoma.

Dose to salivary gland (Gy)* (Range across the gland)

Technique HL tumor dose delivered (Gy) Parotid Submandibular Sublingual
Full mantle 35 17.5 (1.75–30) 31.5 (30–35) 7 (3.5–17.5)
20 10 (1–20) 18 (17–20) 4 (2–10)
Supraclavicular only 20 0.21 (0.12–0.30) 0.43 (0.20–0.56) 0.15 (0.14–0.16)
Neck only 20 10 (1–20) 18 (17–20) 4 (2–10)
Mediastinum only 20 0.12 (0.08–0.16) 0.25 (0.21–0.27) 0.14 (0.13–0.15)
Axilla only 20 0.06 (0.04–0.08) 0.10 (0.06–0.14) 0.07 (0.06–0.08)

Abbreviations: Gy: Gray; HL: Hodgkin lymphoma.

*

Radiation doses to major salivary glands were estimated using methods described by Stovall et al (23).

Upper field border at ear/jaw. Dose to the parotid and sublingual glands have high uncertainty due to their location on the edge of these fields.